GILEAD SCIENCES INC (GILD) Stock Price, Quote, News and Overview
NASDAQ:GILD - Nasdaq - US3755581036 - Common Stock - Currency: USD
GILD Quote, Performance and Key Statistics
GILEAD SCIENCES INC
NASDAQ:GILD (1/31/2025, 4:34:50 PM)
After market: 97.02 -0.18 (-0.19%)97.2
+0.25 (+0.26%)
The current stock price of GILD is 97.2 USD. In the past month the price increased by 5.23%. In the past year, price increased by 26.3%.
GILD Latest News, Press Releases and Analysis
Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts
Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts could pose risks for companies with significant drug exposure.
Will Gilead (GILD) Beat Estimates Again in Its Next Earnings Report?
Gilead (GILD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Gilead Sciences to Release Fourth Quarter & Full Year 2024 Financial Results on Tuesday, February 11, 2025
Demand for Advanced Pancreatic Cancer Treatments at All Time High as Promising Options Come into Focus
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:GSK),(NASDAQ:AZN),(NASDAQ:GILD),(NYSE:BMY) EQNX::TICKER_END
Demand for Advanced Pancreatic Cancer Treatments at All Time High as Promising Options Come into Focus
GILD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 17.11 | 324.98B | ||
| AMGN | AMGEN INC | 14.85 | 153.42B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 905.25 | 118.90B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.81 | 73.95B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.17B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.99B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.83B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.95B | ||
| NTRA | NATERA INC | N/A | 23.36B | ||
| BIIB | BIOGEN INC | 8.81 | 20.97B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 15.86B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.42 | 15.68B |
Related stock screener links
About GILD
Company Profile
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The company is headquartered in Foster City, California and currently employs 18,000 full-time employees. The company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. The company is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The firm operates in more than 35 countries.
Company Info
GILEAD SCIENCES INC
333 Lakeside Dr
Foster City CALIFORNIA 94404 US
CEO: Daniel P. O'Day
Employees: 18000
Company Website: https://www.gilead.com/
Investor Relations: https://investors.gilead.com/
Phone: 16505743000
GILD FAQ
What is the stock price of GILD?
The current stock price of GILD is 97.2 USD.
What is the symbol for GILEAD SCIENCES INC stock?
The exchange symbol of GILEAD SCIENCES INC is GILD and it is listed on the Nasdaq exchange.
On which exchange is GILD stock listed?
GILD stock is listed on the Nasdaq exchange.
Is GILD a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for GILD, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of GILD.
Does GILD stock pay dividends?
GILD has a dividend yield of 3.31%. The yearly dividend amount is currently 3.06.
When does GILD stock report earnings?
GILD will report earnings on 2025-02-11, after the market close.
What is the Price/Earnings (PE) ratio of GILD?
The PE ratio for GILD is 21.94. This is based on the reported non-GAAP earnings per share of 4.43 and the current share price of 97.2 USD.
What is the Short Interest ratio of GILD stock?
The outstanding short interest for GILD is 2.06% of its float.
GILD Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to GILD. When comparing the yearly performance of all stocks, GILD is one of the better performing stocks in the market, outperforming 78.91% of all stocks.
GILD Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to GILD. GILD has an excellent profitability rating, but there are some minor concerns on its financial health.
GILD Financial Highlights
Over the last trailing twelve months GILD reported a non-GAAP Earnings per Share(EPS) of 4.43. The EPS increased by -36.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.45% | ||
| ROA | 0.23% | ||
| ROE | 0.69% | ||
| Debt/Equity | 0 |
GILD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 77% to GILD. The Buy consensus is the average rating of analysts ratings from 38 analysts.
For the next year, analysts expect an EPS growth of -36.07% and a revenue growth 4.47% for GILD